Jonas S, Klein I, Dimant J: Importance of Holter monitoring in patients with periodic cerebral symptoms. Ann Neurol. 1977, 1: 470-474. 10.1002/ana.410010511.
Article
CAS
Google Scholar
Gendelman HE, Linzer M, Gabelman M, Smoller S, Scheuer J: Syncope in a general hospital patient population. Usefulness of the radionuclide brain scan, electroencephalogram, and 24-hour Holter monitor. N Y State J Med. 1983, 83: 1161-1165.
CAS
PubMed
Google Scholar
Bass EB, Curtiss EI, Arena VC, Hanusa BH, Cecchetti A, Karpf M, Kapoor WN: The duration of Holter monitoring in patients with syncope. Is 24 hours enough?. Arch Intern Med. 1990, 150: 1073-1078. 10.1001/archinte.150.5.1073.
Article
CAS
Google Scholar
Linzer M, Yang EH, Estes NAIII, Wang P, Vorperian VR, Kapoor WN: Diagnosing syncope. Part 1: Value of history, physical examination, and electrocardiography. Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med. 1997, 126: 989-996.
Article
CAS
Google Scholar
Sivakumaran S, Krahn AD, Klein GJ, Finan J, Yee R, Renner S, Skanes AC: A prospective randomized comparison of loop recorders versus Holter monitors in patients with syncope or presyncope. Am J Med. 2003, 115: 1-5. 10.1016/S0002-9343(03)00233-X.
Article
Google Scholar
Kapoor WN: Evaluation and management of the patient with syncope. JAMA. 1992, 268: 2553-2560. 10.1001/jama.268.18.2553.
Article
CAS
Google Scholar
Gibson TC, Heitzman MR: Diagnostic efficacy of 24-hour electrocardiographic monitoring for syncope. Am J Cardiol. 1984, 53: 1013-1017. 10.1016/0002-9149(84)90628-3.
Article
CAS
Google Scholar
Linzer M, Yang EH, Estes NAIII, Wang P, Vorperian VR, Kapoor WN: Diagnosing syncope. Part 2: Unexplained syncope. Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med. 1997, 127: 76-86.
Article
CAS
Google Scholar
Zimetbaum P, Kim KY, Ho KK, Zebede J, Josephson ME, Goldberger AL: Utility of patient-activated cardiac event recorders in general clinical practice. Am J Cardiol. 1997, 79: 371-372. 10.1016/S0002-9149(96)00766-7.
Article
CAS
Google Scholar
Zimetbaum PJ, Kim KY, Josephson ME, Goldberger AL, Cohen DJ: Diagnostic yield and optimal duration of continuous-loop event monitoring for the diagnosis of palpitations. A cost-effectiveness analysis. Ann Intern Med. 1998, 128: 890-895.
Article
CAS
Google Scholar
Schuchert A, Maas R, Kretzschmar C, Behrens G, Kratzmann I, Meinertz T: Diagnostic yield of external electrocardiographic loop recorders in patients with recurrent syncope and negative tilt table test. Pacing Clin Electrophysiol. 2003, 26: 1837-1840. 10.1046/j.1460-9592.2003.t01-1-00277.x.
Article
Google Scholar
Kapoor WN, Cha R, Peterson JR, Wieand HS, Karpf M: Prolonged electrocardiographic monitoring in patients with syncope. Importance of frequent or repetitive ventricular ectopy. Am J Med. 1987, 82: 20-28. 10.1016/0002-9343(87)90372-X.
Article
CAS
Google Scholar
Kapoor WN, Karpf M, Maher Y, Miller RA, Levey GS: Syncope of unknown origin. The need for a more cost-effective approach to its diagnosis evaluation. JAMA. 1982, 247: 2687-2691. 10.1001/jama.247.19.2687.
Article
CAS
Google Scholar
Calkins H, Byrne M, el-Atassi R, Kalbfleisch S, Langberg JJ, Morady F: The economic burden of unrecognized vasodepressor syncope. Am J Med. 1993, 95: 473-479. 10.1016/0002-9343(93)90329-N.
Article
CAS
Google Scholar
Fogel RI, Evans JJ, Prystowsky EN: Utility and cost of event recorders in the diagnosis of palpitations, presyncope, and syncope. Am J Cardiol. 1997, 79: 207-208. 10.1016/S0002-9149(96)00717-5.
Article
CAS
Google Scholar
Krahn AD, Klein GJ, Yee R, Manda V: The high cost of syncope: cost implications of a new insertable loop recorder in the investigation of recurrent syncope. Am Heart J. 1999, 137: 870-877. 10.1016/S0002-8703(99)70411-4.
Article
CAS
Google Scholar
Simpson CS, Krahn AD, Klein GJ, Yee R, Skanes AC, Manda V, Norris C: A cost effective approach to the investigation of syncope: relative merit of different diagnostic strategies. Can J Cardiol. 1999, 15: 579-584.
CAS
PubMed
Google Scholar
Nyman JA, Krahn AD, Bland PC, Griffiths S, Manda V: The costs of recurrent syncope of unknown origin in elderly patients. Pacing Clin Electrophysiol. 1999, 22: 1386-1394. 10.1111/j.1540-8159.1999.tb00633.x.
Article
CAS
Google Scholar
Krahn AD, Klein GJ, Yee R, Hoch JS, Skanes AC: Cost implications of testing strategy in patients with syncope: randomized assessment of syncope trial. J Am Coll Cardiol. 2003, 42: 495-501. 10.1016/S0735-1097(03)00659-4.
Article
Google Scholar
Rockx MA, Hoch JS, Klein GJ, Yee R, Skanes AC, Gula LJ, Krahn AD: Is ambulatory monitoring for "community-acquired" syncope economically attractive? A cost-effectiveness analysis of a randomized trial of external loop recorders versus Holter monitoring. Am Heart J. 2005, 150: 1065-10.1016/j.ahj.2005.08.003.
Article
Google Scholar
Fenwick E, Marshall DA, Levy AR, Nichol G: Using and interpreting cost-effectiveness acceptability curves: An example using data from a trial of management strategies for atrial fibrillation. BMC Health Serv Res. 2006, 6: 52-10.1186/1472-6963-6-52.
Article
Google Scholar
Hoch JS, Briggs AH, Willan AR: Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis. Health Econ. 2002, 11: 415-430. 10.1002/hec.678.
Article
Google Scholar
van Hout BA, Al MJ, Gordon GS, Rutten FF: Costs, effects and C/E-ratios alongside a clinical trial. Health Econ. 1994, 3: 309-319.
Article
CAS
Google Scholar
Briggs A, Fenn P: Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. Health Econ. 1998, 7: 723-740. 10.1002/(SICI)1099-1050(199812)7:8<723::AID-HEC392>3.0.CO;2-O.
Article
CAS
Google Scholar
Lothgren M, Zethraeus N: Definition, interpretation and calculation of cost-effectiveness acceptability curves. Health Econ. 2000, 9: 623-630. 10.1002/1099-1050(200010)9:7<623::AID-HEC539>3.0.CO;2-V.
Article
CAS
Google Scholar
Fenwick E, Claxton K, Sculpher M: Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ. 2001, 10: 779-787. 10.1002/hec.635.
Article
CAS
Google Scholar
Fenwick E, O'Brien BJ, Briggs A: Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions. Health Econ. 2004, 13: 405-415. 10.1002/hec.903.
Article
Google Scholar
O'Hagan A, Stevens JW, Montmartin J: Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio. Pharmacoeconomics. 2000, 17: 339-349. 10.2165/00019053-200017040-00004.
Article
CAS
Google Scholar
Spiegelhalter DJ, Abrams KR, Myles JP: Statistics in practice (Chichester, England). Bayesian approaches to clinical trials and health-care evaluation. 2004, Chichester, John Wiley & Sons
Google Scholar
Goodman SN: Introduction to Bayesian methods I: measuring the strength of evidence. Clin Trials. 2005, 2: 282-290. 10.1191/1740774505cn098oa.
Article
Google Scholar
O'Hagan A, Stevens JW: A framework for cost-effectiveness analysis from clinical trial data. Health Econ. 2001, 10: 303-315. 10.1002/hec.617.
Article
CAS
Google Scholar
Stevens JW, O'Hagan A: Incorporation of genuine prior information in cost-effectiveness analysis of clinical trial data. Int J Technol Assess Health Care. 2002, 18: 782-790. 10.1017/S0266462302000594.
Article
Google Scholar
Al MJ, van Hout BA: A Bayesian approach to economic analyses of clinical trials: the case of stenting versus balloon angioplasty. Health Econ. 2000, 9: 599-609. 10.1002/1099-1050(200010)9:7<599::AID-HEC530>3.0.CO;2-#.
Article
CAS
Google Scholar
Stinnett AA, Mullahy J: Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making. 1998, 18: S68-S80.
Article
CAS
Google Scholar
Tambour M, Zethraeus N, Johannesson M: A note on confidence intervals in cost-effectiveness analysis. Int J Technol Assess Health Care. 1998, 14: 467-471.
Article
CAS
Google Scholar
McCrone P, Knapp M, Proudfoot J, Ryden C, Cavanagh K, Shapiro DA, Ilson S, Gray JA, Goldberg D, Mann A, Marks I, Everitt B, Tylee A: Cost-effectiveness of computerised cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial. Br J Psychiatry. 2004, 185: 55-62. 10.1192/bjp.185.1.55.
Article
Google Scholar
Lam DH, McCrone P, Wright K, Kerr N: Cost-effectiveness of relapse-prevention cognitive therapy for bipolar disorder: 30-month study. Br J Psychiatry. 2005, 186: 500-506. 10.1192/bjp.186.6.500.
Article
Google Scholar
Mahoney EM, Mehta S, Yuan Y, Jackson J, Chen R, Gabriel S, Lamy A, Culler S, Caro J, Yusuf S, Weintraub WS: Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation. Am Heart J. 2006, 151: 219-227. 10.1016/j.ahj.2005.02.044.
Article
CAS
Google Scholar